Table 2. Distribution of 61 patients according to immunohistochemistry findings and clinicopathologic variables.
| Variables | Immunohistochemistry |
P value* | |
|---|---|---|---|
| Not altered (%) | Altered (%) | ||
| Histopathologic characteristics: present | 37 (69.81) | 7 (87.5) | 0.423 |
| Mucinous component | 12 (22.64) | 5 (62.5) | 0.032 |
| Signet ring component | 6 (11.32) | 2 (25.0) | 0.280 |
| Medular component | 1 (1.89) | 0 (0) | 1.000 |
| Intra-tumoral lymphocytes | 22 (41.51) | 7 (87.5) | 0.022 |
| Crohn’s-like reaction | 6 (11.32) | 3 (37.5) | 0.087 |
| Expansive | 15 (28.30) | 3 (37.5) | 0.683 |
| Localization: right colon | 4 (8.16) | 5 (41.7) | 0.013 |
| Bethesda 1 | 24 (45.28) | 5 (62.5) | 0.460 |
| Bethesda 2 | 2 (3.77) | 1 (12.5) | 0.349 |
| Bethesda 3 | 18 (33.96) | 6 (75.0) | 0.048 |
| Bethesda 4 | 9 (16.98) | 5 (62.5) | 0.012 |
| Bethesda 5 | 38 (71.70) | 5 (62.5) | 0.683 |
| Bethesda >1 | 27 (50.94) | 8 (100.0) | 0.016 |
| Amsterdam I | 4 (7.55) | 5 (62.5) | 0.001 |
*, Fisher’s exact test.